Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 99,406 | reported | 21 Jul 2020 | tx 10+7,973,144−7,120,144 |
| PRECISION BIOSCIENCES INC | 0 | reported | 01 Apr 2019 | tx 5+4,265,141−8,998,004 |
1 purchase reported after at least 12 months of silence — most recent on 21 Jul 2020.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Jul 2020 | CONVERSION | ALX ONCOLOGY HOLDINGS INC | 3,100,020 | — | |
| 21 Jul 2020 | CONVERSION | ALX ONCOLOGY HOLDINGS INC | 78,175 | — | |
| 21 Jul 2020 | CONVERSION | ALX ONCOLOGY HOLDINGS INC | 3,941,949 | — | |
| 21 Jul 2020 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 850,000 | 19.00 USD | |
| 21 Jul 2020 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 3,000 | 19.00 USD | first after silence |
| 16 Jul 2020 | CONVERSION | ALX ONCOLOGY HOLDINGS INC | 1,052,950 | — | deriv |
| 21 Jul 2020 | CONVERSION | ALX ONCOLOGY HOLDINGS INC | 490,411 | — | deriv |
| 21 Jul 2020 | CONVERSION | ALX ONCOLOGY HOLDINGS INC | 78,175 | — | deriv |
| 21 Jul 2020 | CONVERSION | ALX ONCOLOGY HOLDINGS INC | 3,100,020 | — | deriv |
| 21 Jul 2020 | CONVERSION | ALX ONCOLOGY HOLDINGS INC | 2,398,588 | — | deriv |
| 01 Apr 2019 | PURCHASE | PRECISION BIOSCIENCES INC | 50,000 | 16.00 USD | |
| 01 Apr 2019 | CONVERSION | PRECISION BIOSCIENCES INC | 3,747,623 | — | |
| 01 Apr 2019 | CONVERSION | PRECISION BIOSCIENCES INC | 467,518 | — | |
| 01 Apr 2019 | CONVERSION | PRECISION BIOSCIENCES INC | 8,000,000 | 0.00 USD | deriv |
| 01 Apr 2019 | CONVERSION | PRECISION BIOSCIENCES INC | 998,004 | 0.00 USD | deriv |